Epilepsy
📧 Sign up to get email alerts when something new happens for Epilepsy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-06-02Clinical Trial Update: Evaluation of the Pharmacokinetics, Safety, and Tolerability of TPM XR as Adjunctive Therapy in Pediatric Subjects With Epilepsy [Phase 1, Phase 2]
Phase 1/2 study evaluating the pharmacokinetics, safety, and tolerability of TPM XR as adjunctive therapy in pediatric epilepsy has complete…
-
CLINICAL_TRIALS research · 2016-06-01Clinical Trial Update: Search for Genes Influencing Childhood Absence Epilepsy (CAE) Study
Completed clinical trial investigating genetic factors influencing childhood absence epilepsy. The study aimed to identify genes associated …
-
FDA approval · 2016-05-23FDA Approved: PENTOBARBITAL SODIUM — Original Application (Sagent Pharmaceuticals)
The FDA approved an Original Application (ANDA) for pentobarbital sodium from Sagent Pharmaceuticals, establishing a generic version of this…
-
CLINICAL_TRIALS trial_result · 2016-05-20Clinical Trial Update: Stopping and Preventing Epileptic Seizures Using a Partial Rebreathing Mask [NA]
The University of Aarhus reports completion of a clinical trial evaluating a partial rebreathing mask to stop and prevent epileptic seizures…
-
CLINICAL_TRIALS trial_result · 2016-05-19Clinical Trial Update: Effect of Eslicarbazepine Acetate on the Pharmacokinetics of Gliclazide in Healthy Volunteers [Phase 1]
Phase 1 study evaluating the effect of eslicarbazepine acetate on the pharmacokinetics of gliclazide in healthy volunteers to assess potenti…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA label_change · 2016-05-19FDA Approved: DIVALPROEX SODIUM — Supplemental Application (NorthStar Rx LLC)
FDA supplemental application for divalproex sodium filed by NorthStar Rx LLC, likely involving labeling updates or other product changes. Th…
-
FDA approval · 2016-05-16FDA Approved: FOSPHENYTOIN — Supplemental Application (Fresenius Kabi USA, LLC)
FDA approved a supplemental application for fosphenytoin sodium from Fresenius Kabi USA, LLC under an existing ANDA.
-
CLINICAL_TRIALS trial_result · 2016-05-16Clinical Trial Update: Stress and Seizures - Can a Brief Self-help Book Help? [NA]
A completed clinical trial explored whether a brief self-help book could reduce stress-related seizures in individuals with epilepsy or diss…
-
FDA approval · 2016-05-12FDA Approved: DEPAKOTE ER — Supplemental Application (AbbVie Inc.)
FDA approved a supplemental application for Depakote ER (divalproex sodium) submitted by AbbVie.
-
CLINICAL_TRIALS trial_result · 2016-05-10Clinical Trial Update: Does Body Positioning Affect the Yield of Hyperventilation in Routine Pediatric Electroencephalography - EEG Studies? [NA]
This clinical trial update examines whether body positioning affects the yield of hyperventilation in routine pediatric EEG studies for epil…
-
FDA approval · 2016-04-29FDA Approved: FYCOMPA — Original Application (Eisai Inc.)
The FDA granted original approval for FYCOMPA (perampanel) from Eisai Inc. for add-on therapy in patients with partial-onset seizures, marki…
-
CLINICAL_TRIALS trial_result · 2016-04-22Clinical Trial Update: P-glycoprotein Inhibition as Adjunct Treatment for Medically Refractory Epilepsy. [Phase 2, Phase 3]
There is a terminated Phase 2/3 clinical trial evaluating P-glycoprotein inhibitors as adjunct therapy for medically refractory epilepsy, wi…
-
CLINICAL_TRIALS trial_result · 2016-04-13Clinical Trial Update: Double-blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures [Phase 3]
Phase 3 trial evaluating brivaracetam for adults with partial onset seizures has completed; results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-04-13Clinical Trial Update: Double-blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures [Phase 3]
Phase 3 trial evaluating brivaracetam in adults with partial onset seizures has completed; results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-04-13Clinical Trial Update: A Double-blind, Randomized Conversion to Monotherapy Study to Evaluate the Efficacy and Safety of Brivaracetam in Subjects (≥ 16 to 75 Years Old) With Partial Onset Seizures [Phase 3]
A Phase 3 double-blind, randomized study evaluating brivaracetam monotherapy for partial-onset seizures in adults was terminated but results…
-
CLINICAL_TRIALS trial_result · 2016-04-13Clinical Trial Update: Safety and Tolerability of Intravenous Brivaracetam (Infusion or Bolus) as Adjunctive Antiepileptic Therapy [Phase 3]
A Phase 3 clinical trial assessing the safety and tolerability of intravenous brivaracetam as adjunctive therapy for epilepsy has completed …
-
CLINICAL_TRIALS research · 2016-04-13Clinical Trial Update: External Trigeminal Nerve Stimulation for Drug Resistent Epilepsy [NA]
Clinical trial update on external trigeminal nerve stimulation for drug-resistant epilepsy; the current trial status is unknown.
-
CLINICAL_TRIALS research · 2016-04-13Clinical Trial Update: Epilepsy Impact Scale
This clinical trial update indicates the Epilepsy Impact Scale study sponsored by Stanford University in epilepsy has completed.
-
FDA label_change · 2016-04-06FDA Approved: ZONEGRAN — Supplemental Application (Advanz Pharma (US) Corp.)
FDA approved a supplemental application for ZONEGRAN (zonisamide) submitted by Advanz Pharma (US) Corp.
-
FDA label_change · 2016-04-06FDA Approved: KEPPRA XR — Supplemental Application (UCB, Inc.)
The FDA approved a supplemental application for Keppra XR (levetiracetam) from UCB, Inc., resulting in changes to the product labeling. The …
-
FDA approval · 2016-03-14FDA Approved: GABAPENTIN — Original Application (Ajenat Pharmaceuticals LLC)
FDA approves a new generic gabapentin product (Original Application) by Ajenat Pharmaceuticals LLC under anANDA; the approval covers the sam…
-
CLINICAL_TRIALS trial_result · 2016-03-07Clinical Trial Update: Women With Epilepsy: Pregnancy Outcomes and Deliveries
This is a completed clinical trial update documenting pregnancy outcomes and deliveries in women with epilepsy.
-
FDA approval · 2016-03-03FDA Approved: CEREBYX — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
The FDA approved a supplemental application for Cerebyx (fosphenytoin sodium) submitted by Pfizer Laboratories Div Pfizer Inc.
-
CLINICAL_TRIALS trial_result · 2016-03-01Clinical Trial Update: Immunotherapy in Intractable Cryptogenic Epilepsy Patients With Autoimmune Antibody [Phase 4]
Phase 4 clinical trial update evaluating immunotherapy for patients with intractable cryptogenic epilepsy and autoimmune antibodies; current…
-
FDA approval · 2016-02-26FDA Approved: ZONISAMIDE — Supplemental Application (Exelan Pharmaceuticals, Inc.)
FDA approved a supplemental application for zonisamide (Exelan Pharmaceuticals) under ANDA077869. This action relates to the approved generi…